Literature DB >> 20002338

Sexual concerns and sexual counseling in heart failure.

Mary Medina1, Cynthia Walker, Elaine E Steinke, David W Wright, Victoria Mosack, Mohammad Hussam Farhoud.   

Abstract

Patients with heart failure (HF) face significant challenges in maintaining quality of life (QOL), particularly for sexual intimacy. Although recommended for all cardiac patients, it has been suggested that few HF patients receive sexual counseling. This study explored sexual counseling needs, sexual concerns, and sexual activity using a descriptive survey with HF patients (n = 45), recruited from a HF clinic or cardiology office. Most (77%) had not discussed sexual concerns with a health care professional (HCP). Sexual concerns that were rated as occurring 'occasionally/frequently' included partner overprotectiveness (63%), partner fear of sex (36%), lack of sexual interest (42%), erectile problems (74%), orgasmic difficulties (51%). Frequency of sexual intercourse before HF to present was striking, with 53% reporting no sexual activity in the last 2 months compared with 11% before diagnosis of HF. HCPs must provide sexual counseling to HF patients and partners to enhance QOL and to assist in any adaptations to sexual activity.

Entities:  

Mesh:

Year:  2009        PMID: 20002338     DOI: 10.1111/j.1751-7117.2009.00052.x

Source DB:  PubMed          Journal:  Prog Cardiovasc Nurs        ISSN: 0889-7204


  10 in total

1.  Gender Differences in Sexual Interest or Activity among Adults with Symptomatic Heart Failure.

Authors:  Stacy Fischer; David Bekelman
Journal:  J Palliat Med       Date:  2017-03-20       Impact factor: 2.947

Review 2.  How can heart failure patients and their partners be counseled on sexual activity?

Authors:  Elaine E Steinke
Journal:  Curr Heart Fail Rep       Date:  2013-09

Review 3.  Erectile dysfunction as a complication of heart failure.

Authors:  Afshan Baraghoush; Anita Phan; Robert D Willix; Ernst R Schwarz
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 4.  Sexual dysfunction in heart failure patients.

Authors:  Tiny Jaarsma; Bengt Fridlund; Jan Mårtensson
Journal:  Curr Heart Fail Rep       Date:  2014-09

5.  Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.

Authors:  Alvin Chandra; Eldrin F Lewis; Brian L Claggett; Akshay S Desai; Milton Packer; Michael R Zile; Karl Swedberg; Jean L Rouleau; Victor C Shi; Martin P Lefkowitz; Tzvetana Katova; John J V McMurray; Scott D Solomon
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

6.  Sexual dysfunction in males with systolic heart failure and associated factors.

Authors:  Sharareh Zeighami Mohammadi; Mandana Shahparian; Farzad Fahidy; Ebrahim Fallah
Journal:  ARYA Atheroscler       Date:  2012

7.  Participants' Experiences of a Sexual Counseling Intervention During Cardiac Rehabilitation: A Nested Qualitative Study Within the CHARMS Pilot Randomized Controlled Trial.

Authors:  Maureen D'Eath; Molly Byrne; Patrick Murphy; Tiny Jaarsma; Jenny McSharry; Andrew W Murphy; Sally Doherty; Chris Noone; Dympna Casey
Journal:  J Cardiovasc Nurs       Date:  2018 Sep/Oct       Impact factor: 2.083

8.  Sexual Activity in Heart Failure Patients: Information Needs and Association with Health-Related Quality of Life.

Authors:  Anneleen Baert; Sofie Pardaens; Delphine De Smedt; Paolo Emilio Puddu; Maria Costanza Ciancarelli; Amos Dawodu; Johan De Sutter; Dirk De Bacquer; Els Clays
Journal:  Int J Environ Res Public Health       Date:  2019-05-05       Impact factor: 3.390

Review 9.  Sex, Rhythm & Death: The effect of sexual activity on cardiac arrhythmias and sudden cardiac death.

Authors:  Cicely Anne Dye; Erica Engelstein; Sean Swearingen; Jeanine Murphy; Timothy Larsen; Annabelle Santos Volgman
Journal:  Front Cardiovasc Med       Date:  2022-09-26

Review 10.  Sexual counseling and cardiovascular disease: practical approaches.

Authors:  Elaine E Steinke; Tiny Jaarsma
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.